Deutsche medizinische Wochenschrift
-
Dtsch. Med. Wochenschr. · Nov 2003
Case Reports[Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities].
A 48-year-old diabetic with multiple co-morbidities presented with generalized micro- and macroangiopathy including peripheral artery disease stage IV with necroses in several digits of both feet. He was admitted to the department of surgery for the insertion of femoropopliteal bypasses. ⋯ S. boulardii (synonym: S. cerevisiae) is considered an non-pathogenic probiotic yeast, and live yeast cells are used for supportive therapy of diarrhea. The present case and a review of the literature demonstrate that fungemia and sepsis are rare complications of the administration of S. boulardii in immunocompromised patients. For this reason the therapeutic usage of probiotics should be carefully considered regarding its risk-benefit potential.
-
Dtsch. Med. Wochenschr. · Oct 2003
Review Comparative Study[Visceral adipose tissue and metabolic syndrome].
-
Dtsch. Med. Wochenschr. · Oct 2003
Review Comparative Study[Smoking and body weight--a main topic].